Holocene Advisors
AMED

Holocene Advisors’s Amedisys AMED Stock Holding History

Holocene Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-79,036
Closed -$7.63M – 751
2024
Q3 		$7.63M Buy
79,036
+62,953
+391% +$6.14M 0.03% 281
2024
Q2 		$1.48M Buy
+16,083
New +$1.49M 0.01% 566
2024
Q1 		– Sell
-30,493
Closed -$2.9M – 702
2023
Q4 		$2.9M Sell
30,493
-17,433
-36% -$1.63M 0.01% 459
2023
Q3 		$4.48M Buy
+47,926
New +$4.43M 0.02% 408
2022
Q2 		– Sell
-9,413
Closed -$1.62M – 806
2022
Q1 		$1.62M Buy
+9,413
New +$1.41M 0.01% 583
2021
Q4 		– Sell
-35,669
Closed -$5.32M – 847
2021
Q3 		$5.32M Buy
35,669
+28,055
+368% +$5.83M 0.03% 327
2021
Q2 		$1.86M Buy
7,614
+1,183
+18% +$310K 0.01% 576
2021
Q1 		$1.7M Buy
+6,431
New +$1.81M 0.01% 617
2019
Q1 		– Sell
-3,584
Closed -$420K – 638
2018
Q4 		$420K Buy
+3,584
New +$422K 0.01% 464

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Holocene Advisors's AMED Position: Q4 2024 in Review

Holocene Advisors sold out of Amedisys (AMED) in Q4 2024, closing a stake of 79,036 shares — an estimated $7.63M sold.

Holocene Advisors first reported a position in AMED in Q4 2018 and held it in 9 quarters. The position peaked at $7.63M in Q3 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

  • Holocene Advisors reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
  • Holocene Advisors sold 79,036 Amedisys shares in Q4 2024, an estimated $7.63M.
  • Holocene Advisors first reported a position in Amedisys in Q4 2018 and held it in 9 quarters.
  • Holocene Advisors's Amedisys position peaked at $7.63M in Q3 2024.
  • 290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Holocene Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.